Continuing Access to In-Home IVIG Act

Bill: 116-hr-7839
Sponsor: full_name: Rep. Matsui, Doris O. [D-CA-6]
Introduced: 2020-07-29
Policy area: Health
Subjects: Congressional oversight

Drug therapy

Government studies and investigations

Health programs administration and funding

Health technology, devices, supplies

Hereditary and development disorders

Home and outpatient care

Immunology and vaccination

Medicare
Latest action: action_date: 2020-07-29
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2020-07-29
action_desc: Introduced in House
text: <p><b>Continuing Access to In-Home IVIG Act</b></p> <p>This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.</p>

tv_txt: I 116th CONGRESS 2d Session H. R. 7839 IN THE HOUSE OF REPRESENTATIVES July 29, 2020 Ms. Matsui (for herself and Mr. Brady ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Patient IVIG Access Demonstration Project.

1. Short title This Act may be cited as the Continuing Access to In-Home IVIG Act . 2. Extension of Medicare patient IVIG access demonstration project (a) Extension of demonstration project Section 101(b) of the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 ( 42 U.S.C. 13951 note) is amended— (1) by striking paragraph (1) and inserting the following: (1) Duration Beginning not later than one year after the date of enactment of this Act, the Secretary shall conduct the demonstration project for a period of 3 years and, subject to the availability of funds under subsection (g), the period beginning on October 1, 2017, and ending on December 31, 2022. ; and (2) in paragraph (2)— (A) by striking 4,000 and inserting 6,500 ; and (B) by striking 2020 and inserting 2022 . (b) Updated evaluation and report Section 101(f) is amended— (1) by redesignating paragraph (2) as paragraph (3); and (2) by inserting after paragraph (1) the following new paragraph: (2) Updated evaluation and report Not later than one year after the date of the enactment of the Continuing Access to In-Home IVIG Act, the Secretary shall submit to Congress an updated report that contains the following: (A) The total number of beneficiaries enrolled in the demonstration project during the updated report period. (B) The total number of claims submitted for services during the updated report period, disaggregated by month. (C) An analysis of the impact of the demonstration on beneficiary access to the in-home administration of intravenous immune globin, including the impact on beneficiary health and well-being. (D) An analysis of the impact of in-home administration of intravenous immune globin on overall costs to Medicare, including the cost differential between in-home administration of intravenous immune globin and administration of intravenous immune globin in a healthcare facility. (E) A survey of providers and enrolled beneficiaries that participated in the demonstration project that identifies barriers to accessing services, including reimbursement for items and services. (F) Recommendations to Congress on the appropriateness of establishing a permanent bundled services payment for the in-home administration of intravenous immune globin for Medicare beneficiaries. . (c) Definition of updated report period Section 101(h) is amended by adding at the end the following new paragraph: (4) Updated report period The term updated report period means the period beginning on October 1, 2014, and ending on September 30, 2020. .